InMed Pharmaceuticals Inc. (INM) — Dilution Risk Analysis
Current Snapshot
InMed Pharmaceuticals Inc. (INM) has a DilutionWatch score of 77/10 and is classified as CRITICAL risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 77/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
2 shelf registration or ATM offering filings detected in recent history.
Recent filing forms in the source payload: 8-K 1, 424B5 1, EFFECT 1, S-3 1, XBRL 1.
| Form | Filed | Accession |
|---|---|---|
| 8-K | 2026-04-27 | 0001213900-26-048064 |
| 424B5 | 2026-04-03 | 0001213900-26-039938 |
| EFFECT | 2026-03-30 | 9999999995-26-000999 |
| S-3 | 2026-03-20 | 0001213900-26-032416 |
| xbrl | 2025-06-30 | xbrl-7386-xbrl_warrant |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Shelf registration capacity | $50,000,000 | Source |
| ATM offering capacity remaining | $1,213,648 | Source |
| Cash runway | 7 months | Source |
| Three-year share count growth | 2376.0% | Source |
DilutionWatch Analysis
- Risk Level
- CRITICAL (Score: 77/10) Source
- Cash Runway
- 7 months Source
- ATM Offering Capacity Remaining
- $1,213,648 Source
- Shelf Registration Capacity
- $50,000,000 Source
- Share Count Growth (3-Year)
- 2376.0% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.